CCA
BSX icon

Carrera Capital Advisors’s Boston Scientific BSX Stock Holding History

Carrera Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,859
Closed -$273K – 191
2025
Q4 		$273K Buy
2,859
+366
+15% +$35.9K 0.05% 138
2025
Q3 		$243K Buy
2,493
+134
+6% +$13.9K 0.04% 129
2025
Q2 		$253K Hold
2,359
– – 0.05% 126
2025
Q1 		$238K Hold
2,359
– – 0.05% 139
2024
Q4 		$211K Buy
+2,359
New +$208K 0.05% 131

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Carrera Capital Advisors's BSX Position: Q1 2026 in Review

Carrera Capital Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,859 shares — an estimated $273K sold.

Carrera Capital Advisors first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $273K in Q4 2025. 1,682 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Carrera Capital Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Carrera Capital Advisors sold 2,859 Boston Scientific shares in Q1 2026, an estimated $273K.
  • Carrera Capital Advisors first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
  • Carrera Capital Advisors's Boston Scientific position peaked at $273K in Q4 2025.
  • 1,682 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Carrera Capital Advisors's 13F filing for Q1 2026, filed 4 May 2026.